Literature DB >> 32945856

The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit.

Joseph Miller1,2,3, Raef A Fadel1, Amy Tang1,4, Giuseppe Perrotta1,3, Erica Herc1,2, Sandeep Soman1, Sashi Nair1, Zachary Hanna1, Marcus J Zervos1,2, George Alangaden1,2, Indira Brar1,2, Geehan Suleyman1.   

Abstract

BACKGROUND: The relationship of health disparities and comorbidities in coronavirus disease 2019 (COVID-19)-related outcomes are an ongoing area of interest. This report assesses risk factors associated with mortality in patients presenting with COVID-19 infection and healthcare disparities.
METHODS: We conducted a retrospective cohort study of consecutive patients presenting to emergency departments within an integrated health system who tested positive for COVID-19 between 7 March and 30 April 2020 in metropolitan Detroit. The primary outcomes were hospitalization and 30-day mortality.
RESULTS: A total of 3633 patients with a mean age of 58 years were included. The majority were female and Black non-Hispanic. Hospitalization was required for 64% of patients, 56% of whom were Black. Hospitalized patients were older, more likely to reside in a low-income area, and had a higher burden of comorbidities. By 30 days, 433 (18.7%) hospitalized patients died. In adjusted analyses, the presence of comorbidities, an age >60 years, and more severe physiological disturbance were associated with 30-day mortality. Residence in low-income areas (odds ratio [OR], 1.02; 95% confidence interval [CI], .76-1.36) and public insurance (OR, 1.24; 95% CI, .76-2.01) were not independently associated with a higher risk of mortality. Black female patients had a lower adjusted risk of mortality (OR, 0.46; 95% CI, .27-.78).
CONCLUSIONS: In this large cohort of COVID-19 patients, those with comorbidities, advanced age, and physiological abnormalities on presentation had higher odds of death. Disparities in income or source of health insurance were not associated with outcomes. Black women had a lower risk of dying.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; Detroit; SARS-CoV-2; mortality; outcomes

Mesh:

Year:  2021        PMID: 32945856      PMCID: PMC7543348          DOI: 10.1093/cid/ciaa1420

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Disparities in Coronavirus Disease 2019 Outcomes for African Americans: More Studies Are Warranted.

Authors:  Shiva Mehravaran; Hussien Ahmed H Abdelgawad; Yun-Chi Chen
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

2.  Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality.

Authors:  Alaa Abu Sayf; Raef Fadel; Ashley Scott; Layla Al Bizri; Wing Tai Kong; Mohamed Rezik; Katherine Joyce; Yusuf Alalwan; Mohamed Dabaja; Sashi Nair; Krishna Modi; Indira Brar; Geehan Suleyman; Jennifer Swiderek; Geneva Tatem; Joseph Miller; Gillian Grafton; Daniel R Ouellette
Journal:  Crit Care Explor       Date:  2021-03-26

Review 3.  Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis.

Authors:  Xueya Han; Jie Xu; Hongjie Hou; Haiyan Yang; Yadong Wang
Journal:  Int Immunopharmacol       Date:  2021-11-22       Impact factor: 4.932

Review 4.  Hospitalised versus outpatient COVID-19 patients' background characteristics and comorbidities: A systematic review and meta-analysis.

Authors:  Paola P Mattey-Mora; Connor A Begle; Candice K Owusu; Chen Chen; Maria A Parker
Journal:  Rev Med Virol       Date:  2021-10-21       Impact factor: 11.043

5.  Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More.

Authors:  Seema Joshi; Zachary Smith; Sana Soman; Saniya Jain; Atheel Yako; Marwa Hojeij; Louis Massoud; Ayman Alsaadi; Jonathan Williams; Rachel Kenney; Joseph Miller; George Alangaden; Mayur Ramesh
Journal:  Open Forum Infect Dis       Date:  2021-12-08       Impact factor: 3.835

6.  Risk of hospitalization and mortality due to COVID-19 in people with obesity: An analysis of data from a Brazilian state.

Authors:  Erika Cardoso Dos Reis; Phillipe Rodrigues; Tatielle Rocha de Jesus; Elma Lúcia de Freitas Monteiro; Jair Sindra Virtuoso Junior; Lucas Bianchi
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

7.  Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections.

Authors:  Geehan Suleyman; Raef Fadel; Indira Brar; Rita Kassab; Rafa Khansa; Nicholas Sturla; Ayman Alsaadi; Katie Latack; Joseph Miller; Robert Tibbetts; Linoj Samuel; George Alangaden; Mayur Ramesh
Journal:  Open Forum Infect Dis       Date:  2022-03-07       Impact factor: 4.423

8.  Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 - A multicenter retrospective observation study.

Authors:  James P d'Etienne; Naomi Alanis; Eric Chou; John S Garrett; Jessica J Kirby; David P Bryant; Sajid Shaikh; Chet D Schrader; Hao Wang
Journal:  Am J Emerg Med       Date:  2022-03-10       Impact factor: 4.093

Review 9.  The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.

Authors:  Shuwen Li; Jiahao Ren; Hongjie Hou; Xueya Han; Jie Xu; Guangcai Duan; Yadong Wang; Haiyan Yang
Journal:  Neurol Sci       Date:  2022-03-24       Impact factor: 3.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.